These findings suggested that NSC23766 inhibits CAMSAP2-mediated HCC invasion and metastasis by interrupting Rac1/JNK/c-Jun signaling and may provide a novel therapeutic option for HCC. Here, MAPK8 is linked to hepatocellular carcinoma.